Pipeline
Our pharmaceutical roadmap embodies an ambitious yet systematic approach toward innovative healthcare solutions.
| Drug | Patent | Disease | Target |
|---|---|---|---|
|
NM-101 (First-in-class) |
Application number 10-2023-0157774 |
Atopic dermatitis | CLEC10A |
|
NM-201 (First-in-class) |
Application number 10-2023-0157775 |
Psoriasis | ADAM9 |
|
NM-301 (First-in-class) |
Application number 10-2023-0157776 |
NASH | ANGPTL8 |
|
NM-302 (First-in-class) |
Application number 10-2023-0162828 |
NASH | SCD |
|
NM-401 (First-in-class) |
- | Obesity | - |
|
NM-501 (First-in-class) |
- | Diabetes | - |